101 related articles for article (PubMed ID: 24362350)
1. Amino and carboxy functionalized modified nucleosides: a potential class of inhibitors for angiogenin.
Debnath J; Dasgupta S; Pathak T
Bioorg Chem; 2014 Feb; 52():56-61. PubMed ID: 24362350
[TBL] [Abstract][Full Text] [Related]
2. Dinucleosides with non-natural backbones: a new class of ribonuclease A and angiogenin inhibitors.
Debnath J; Dasgupta S; Pathak T
Chemistry; 2012 Feb; 18(6):1618-27. PubMed ID: 22262583
[TBL] [Abstract][Full Text] [Related]
3. Comparative inhibitory activity of 3'- and 5'-functionalized nucleosides on ribonuclease A.
Debnath J; Dasgupta S; Pathak T
Bioorg Med Chem; 2010 Dec; 18(23):8257-63. PubMed ID: 21041096
[TBL] [Abstract][Full Text] [Related]
4. Direct binding of recombinant plasminogen kringle 1-3 to angiogenin inhibits angiogenin-induced angiogenesis in the chick embryo CAM.
Youn MR; Park MH; Choi CK; Ahn BC; Kim HY; Kang SS; Hong YK; Joe YA; Kim JS; You WK; Lee HS; Chung SI; Chang SI
Biochem Biophys Res Commun; 2006 May; 343(3):917-23. PubMed ID: 16564503
[TBL] [Abstract][Full Text] [Related]
5. Nucleoside-amino acid conjugates: An alternative route to the design of ribonuclease A inhibitors.
Debnath J; Dasgupta S; Pathak T
Bioorg Med Chem; 2009 Jul; 17(14):4921-7. PubMed ID: 19540766
[TBL] [Abstract][Full Text] [Related]
6. Evidence for Novel Action at the Cell-Binding Site of Human Angiogenin Revealed by Heteronuclear NMR Spectroscopy, in silico and in vivo Studies.
Chatzileontiadou DSM; Tsika AC; Diamantopoulou Z; Delbé J; Badet J; Courty J; Skamnaki VT; Parmenopoulou V; Komiotis D; Hayes JM; Spyroulias GA; Leonidas DD
ChemMedChem; 2018 Feb; 13(3):259-269. PubMed ID: 29314771
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and ribonuclease A inhibition activity of resorcinol and phloroglucinol derivatives of catechin and epicatechin: Importance of hydroxyl groups.
Dutta S; Basak A; Dasgupta S
Bioorg Med Chem; 2010 Sep; 18(17):6538-46. PubMed ID: 20692173
[TBL] [Abstract][Full Text] [Related]
8. 3'-N-Alkylamino-3'-deoxy-ara-uridines: a new class of potential inhibitors of ribonuclease A and angiogenin.
Maiti TK; Soumya De ; Dasgupta S; Pathak T
Bioorg Med Chem; 2006 Feb; 14(4):1221-8. PubMed ID: 16216513
[TBL] [Abstract][Full Text] [Related]
9. Exploring the potential of 3'-O-carboxy esters of thymidine as inhibitors of ribonuclease A and angiogenin.
Ghosh KS; Debnath J; Dutta P; Sahoo BK; Dasgupta S
Bioorg Med Chem; 2008 Mar; 16(6):2819-28. PubMed ID: 18226913
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of ribonuclease A by nucleoside-dibasic acid conjugates.
Debnath J; Dasgupta S; Pathak T
Bioorg Med Chem; 2009 Sep; 17(18):6491-5. PubMed ID: 19713115
[TBL] [Abstract][Full Text] [Related]
11. Identification of small-molecule inhibitors of human angiogenin and characterization of their binding interactions guided by computational docking.
Jenkins JL; Shapiro R
Biochemistry; 2003 Jun; 42(22):6674-87. PubMed ID: 12779322
[TBL] [Abstract][Full Text] [Related]
12. 5'-O-tritylated nucleoside derivatives: inhibition of thymidine phosphorylase and angiogenesis.
Liekens S; Bronckaers A; Hernández AI; Priego EM; Casanova E; Camarasa MJ; Pérez-Pérez MJ; Balzarini J
Mol Pharmacol; 2006 Aug; 70(2):501-9. PubMed ID: 16675660
[TBL] [Abstract][Full Text] [Related]
13. Site-directed mutagenesis of histidine-13 and histidine-114 of human angiogenin. Alanine derivatives inhibit angiogenin-induced angiogenesis.
Shapiro R; Vallee BL
Biochemistry; 1989 Sep; 28(18):7401-8. PubMed ID: 2479414
[TBL] [Abstract][Full Text] [Related]
14. Human placental ribonuclease inhibitor abolishes both angiogenic and ribonucleolytic activities of angiogenin.
Shapiro R; Vallee BL
Proc Natl Acad Sci U S A; 1987 Apr; 84(8):2238-41. PubMed ID: 3470787
[TBL] [Abstract][Full Text] [Related]
15. 5'-Modified pyrimidine nucleosides as inhibitors of ribonuclease A.
Samanta A; Dasgupta S; Pathak T
Bioorg Med Chem; 2011 Apr; 19(7):2478-84. PubMed ID: 21420869
[TBL] [Abstract][Full Text] [Related]
16. Development of antiangiogenin peptide using a phage-displayed peptide library.
Gho YS; Lee JE; Oh KS; Bae DG; Chae CB
Cancer Res; 1997 Sep; 57(17):3733-40. PubMed ID: 9288781
[TBL] [Abstract][Full Text] [Related]
17. Enhancement of angiogenin inhibition by polyphenol-capped gold nanoparticles.
Panda A; Karhadkar S; Acharya B; Banerjee A; De S; Dasgupta S
Biopolymers; 2021 Jul; 112(7):e23429. PubMed ID: 33851721
[TBL] [Abstract][Full Text] [Related]
18. A small-molecule inhibitor of the ribonucleolytic activity of human angiogenin that possesses antitumor activity.
Kao RY; Jenkins JL; Olson KA; Key ME; Fett JW; Shapiro R
Proc Natl Acad Sci U S A; 2002 Jul; 99(15):10066-71. PubMed ID: 12118120
[TBL] [Abstract][Full Text] [Related]
19. Replacement of residues 8-22 of angiogenin with 7-21 of RNase A selectively affects protein synthesis inhibition and angiogenesis.
Bond MD; Vallee BL
Biochemistry; 1990 Apr; 29(13):3341-9. PubMed ID: 1692238
[TBL] [Abstract][Full Text] [Related]
20. Ribonuclease A inhibition by carboxymethylsulfonyl-modified xylo- and arabinopyrimidines.
Datta D; Dasgupta S; Pathak T
ChemMedChem; 2014 Sep; 9(9):2138-49. PubMed ID: 25125220
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
